Additionally, platelet-derived growth factor receptor-beta (PDGFR-β), which is greatly increased in T-EVs discharged by melanoma cells resistant to the BRAF inhibitor PLX4720, can be transported to recipient melanoma cells. This evidence concerns the gene PDGFRB and melanoma.